[ Price : $8.95]
Former FDA chief counsel Mark Raza joins Hogan Lovells Cadwalader as senior counsel in its Pharmaceuticals and Biotechnology pract...[ Price : $8.95]
FDA grants breakthrough therapy designation for UCBs Cimzia in some pregnant women with antiphospholipid syndrome.[ Price : $8.95]
FDA issues a guidance entitled Temporary Policies for Compounding Certain Starter Parenteral Nutrition Drug Products for Neonates ...[ Price : $8.95]
FDA warns Stephen Fallon of Wilton Manors, FL, about bioresearch violations in his role as clinical investigator of a trial of an ...[ Price : $8.95]
FDA cautions Fenwal International about CGMP deviations at its Maricao, Puerto Rico, facility that manufactures blood pack units.[ Price : $8.95]
FDA solicits public comment on a proposed study to learn from healthcare providers their understanding of barriers to higher patie...[ Price : $8.95]
FDA cites Travere Therapeutics over promotional materials for Filspari (sparsentan) because they contain misleading claims about t...[ Price : $8.95]
FDA accepts for priority review an Intellia Therapeutics BLA for lonvo-z, an in vivo CRISPR-based therapy for treating hereditary ...